In an SEC filing today, Coronado Biosciences (Nasdaq: CNDO) nominated Harlan F. Weisman, M.D. as a director nominee. Dr. Weisman is the founder and Managing Director of And-One Consulting, LLC, a consulting firm which was formed in March 2012 and focuses on assisting companies formulate and lead successful global strategies for accelerating medical product development, regulatory approval and market acceptance.
From October 2005 to March 2012, Dr. Weisman was Chief Science and Technology Officer of Johnson and Johnson’s (NYSE: JNJ) Medical Device and Diagnostics business. Dr. Weisman is a graduate of the University of Maryland and the University of Maryland School of Medicine. Dr. Weisman served his residency at Mount Sinai Hospital in New York and was a fellow in cardiovascular disease at Johns Hopkins Hospital.
From October 2005 to March 2012, Dr. Weisman was Chief Science and Technology Officer of Johnson and Johnson’s (NYSE: JNJ) Medical Device and Diagnostics business. Dr. Weisman is a graduate of the University of Maryland and the University of Maryland School of Medicine. Dr. Weisman served his residency at Mount Sinai Hospital in New York and was a fellow in cardiovascular disease at Johns Hopkins Hospital.